Three preparations of BCG, currently in use for clinical trials in cancer, were tested for relative potency as an immunological adjuvant. Using a lymphocyte trapping assay, Pasteur Institute BCG was shown to be a more effective adjuvant than the Tice strain or the Glaxo preparation of BCG.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000225289 | DOI Listing |
Publication Analysis
Top Keywords
comparison adjuvant
4
adjuvant three
4
bcg
4
three bcg
4
bcg preparations
4
preparations mice
4
mice three
4
three preparations
4
preparations bcg
4
bcg currently
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!